Pharma2026-11-02 01:34 UTC
Thailand Leverages AI to Develop Cancer Medicines
Thailand is using artificial intelligence to develop new cancer medicines, with a focus on precision therapy.
The Thai government has launched an initiative to apply AI in cancer research and treatment, partnering with private sector companies and research institutions.
The project aims to develop personalized cancer medicines using AI-driven simulations and virtual replicas of cancer cells.
This approach is expected to improve the effectiveness of cancer treatments and reduce side effects.
Source: Toute la Thaïlande — read the original article
This article is an independent rewrite and summary, not a reproduction of the original.
← back to feed
This article is an independent rewrite and summary, not a reproduction of the original.